Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alternativeName |
Etanidazole
SR-2508 |
| gptkbp:CASNumber |
994-19-8
|
| gptkbp:chemicalClass |
nitroimidazole
|
| gptkbp:drugClass |
radiosensitizer
|
| gptkbp:hasInChIKey |
QKQKRCQVRVQKQR-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C6H10N4O3
|
| gptkbp:hasSMILES |
CC1=NC=C([N+](=O)[O-])N1CCO
|
| gptkbp:hasTherapeuticUse |
gptkb:cancer
|
| gptkbp:hasUNII |
6QX8QG63UV
|
| https://www.w3.org/2000/01/rdf-schema#label |
NSC 609699
|
| gptkbp:investigatedBy |
hypoxic tumor radiosensitization
|
| gptkbp:IUPACName |
1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole
|
| gptkbp:mechanismOfAction |
enhances effect of radiation therapy
|
| gptkbp:molecularWeight |
186.17 g/mol
|
| gptkbp:PubChem_CID |
3124
3237 |
| gptkbp:relatedTo |
gptkb:metronidazole
nimorazole |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:synonym |
Etanidazol
Etanidazolum |
| gptkbp:bfsParent |
gptkb:topotecan
|
| gptkbp:bfsLayer |
7
|